These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18524689)

  • 1. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis.
    Sugumar A; Singh A; Pasricha PJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):726-33. PubMed ID: 18524689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
    Heckert J; Parkman HP
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
    Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
    Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
    Soykan I; Sarosiek I; McCallum RW
    Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort.
    Schey R; Saadi M; Midani D; Roberts AC; Parupalli R; Parkman HP
    Dig Dis Sci; 2016 Dec; 61(12):3545-3551. PubMed ID: 27530760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.
    Silvers D; Kipnes M; Broadstone V; Patterson D; Quigley EM; McCallum R; Leidy NK; Farup C; Liu Y; Joslyn A
    Clin Ther; 1998; 20(3):438-53. PubMed ID: 9663360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e291-e304. PubMed ID: 31897312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis.
    Farup CE; Leidy NK; Murray M; Williams GR; Helbers L; Quigley EM
    Diabetes Care; 1998 Oct; 21(10):1699-706. PubMed ID: 9773734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
    Dumitrascu DL; Weinbeck M
    Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on Tangweikang in treating diabetic gastroparesis].
    Jiang RQ; Zhang DX; Bai CY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb; 27(2):114-6. PubMed ID: 17342995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual role of domperidone in gastroparesis and lactation.
    Phan H; DeReese A; Day AJ; Carvalho M
    Int J Pharm Compd; 2014; 18(3):203-7. PubMed ID: 25306766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokinetics in patients with gastroparesis: a systematic analysis.
    Sturm A; Holtmann G; Goebell H; Gerken G
    Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium.
    Sarosiek I; Van Natta M; Parkman HP; Abell T; Koch KL; Kuo B; Shulman RJ; Farrugia G; Grover M; Hamilton FA; Pasricha PJ; Yates KP; Miriel L; Wilson L; Yamada G; Tonascia J; McCallum RW;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e452-e464. PubMed ID: 34089855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: The diagnosis and management of gastroparesis.
    Haans JJ; Masclee AA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.
    Parkman HP; Jacobs MR; Mishra A; Hurdle JA; Sachdeva P; Gaughan JP; Krynetskiy E
    Dig Dis Sci; 2011 Jan; 56(1):115-24. PubMed ID: 21063774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
    Janssen P; Harris MS; Jones M; Masaoka T; Farré R; Törnblom H; Van Oudenhove L; Simrén M; Tack J
    Am J Gastroenterol; 2013 Sep; 108(9):1382-91. PubMed ID: 24005344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic gastroparesis.
    Kong MF; Horowitz M
    Diabet Med; 2005 Sep; 22 Suppl 4():13-8. PubMed ID: 16109013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.